Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT trial)
Hims CEO Andrew Dudum said the partnership with Novo followed his company's decision to shift its weight-loss business away from compounded GLP-1 drugs and toward branded, FDA-approved treatments, reflecting what he said was rising demand for a wider range of lower-cost options
Whether you have a question about a small mark on your skin or how to manage nausea, we are here to ensure you feel supported
Your doctor will assess your body weight, body mass index, blood sugar levels, and medical history to create a customized treatment plan for you
3 Ways to Manage Diarrhea While Taking Ozempic if You Experience Diarrhea While Taking Ozempic, Managing Diarrhea and Other Gastrointestinal Adverse Events Is Important for Your Comfort and Treatment Adherence
GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects
